Neuropeptide kyotorphin (tyrosyl-arginine) has decreased levels in the cerebro-spinal fluid of Alzheimer's disease patients: Potential diagnostic and pharmacological implications

Frontiers in Aging Neuroscience

Volumn 5, Issue OCT, 2013, Pages

  Santos, Sara Matos ^a   Garcia Nimo, Laura ^b   Santos, Sónia Sá ^a   Tavares, Isaura ^c   Cocho, José A ^b   Castanho, Miguel A R B ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b University Hospital of Santiago de Compostela   (Spain)

^c University of Porto   (Portugal)

Author keywords

Alzheimer; Cerebro spinal fluid; Drug; Kyotorphin; Neuroprotection; Pain

Indexed keywords

BIOLOGICAL MARKER; KYOTORPHIN; NEUROPEPTIDE; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NERVE DEGENERATION; PROTEIN PHOSPHORYLATION;

EID: 84895829915     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00068     Document Type: Article

References (34)

1. Arima, T., Kitamura, Y., Nishiya, T., Takagi, H., and Nomura, Y. (1996). Kyotorphin (L-tyrosyl-L-arginine) as a possible substrate for inducible nitric oxide synthase in rat glial cells. Neurosci. Lett. 212, 1-4. doi: 10.1016/0304-3940(96)12758-0.
2. Arima, T., Kitamura, Y., Nishiya, T., Taniguchi, T., Takagi, H., and Nomura, Y. (1997). Effects of kyotorphin (L-tyrosyl-L-arginine) ON[3H]NG-nitro-L-arginine binding to neuronal nitric oxide. Neurochem. Int. 30, 605-611. doi:10.1016/S0197-0186(96)00098-8.
3. Benedetti, F., Vighetti, S., Ricco, C., Lagna, E., Bergamasco, B., and Pinessi, L. (1999). Pain threshold and tolerance in Alzheimer's disease. Pain 80, 377-382. doi:10.1016/S0304-3959(98)00228-0.
4. Blennow, K. (2004). Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 1, 213-225. doi:10.1602/neurorx.1.2.213.
5. Blennow, K., Hampel, H., Weiner, M., and Zetterberg, H. (2010). Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat. Rev. Neurol. 6, 131-144. doi:10.1038/nrneurol.2010.4.
6. Bocheva, A. I., and Dzambazova-Maximova, E. B. (2004). Effects of kyotorphin and analogues on nociception and pentylenetetrazole seizures. Folia Med. 46, 40-44.
7. Borsook, D. (2012). Neurological diseases and pain. Brain 135, 320-344. doi:10.1093/brain/awr271.
8. de la Torre, J. C., and Stefano, G. B. (2000). Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res. Rev. 34, 119-136. doi:10.1016/S0165-0173(00)00043-6.
9. Dzambazova, E., and Bocheva, A. (2010). The unique brain dipeptide kyotorphin-from discovery to nowadays. J. Biomed. Clin. Res. 3, 3-11.
10. Farrell, M. J., Katz, B., and Helme, R. D. (1996). The impact of dementia on the pain experience. Pain 67, 7-15. doi:10.1016/0304-3959(96)03041-2.
11. Godlevsky, L. S., Shandra, A. A., Mikhaleva, I., Vastyanov, R. S., and Mazarati, A. M. (1995). Seizure-protecting effects of kyotorphin and related peptides in an animal model of epilepsy. Brain Res. Bull. 37, 223-226. doi:10.1016/0361-9230(94)00274-5.
12. Gorenkova, N. A., Nazarenko, I. V., Samorukova, I. V., Avrushchenko, M., and Volkov, A. V. (2002). Therapy of postresuscitation behavioral disorders with mexidol and kyotorphin. Anesteziol. Reanimatol. 6, 63-66.
13. Ignat'ev, D. A., Vorob'ev, V. V., and Ziganshin, R. K. H. (1998). Effects of a number of short peptides isolated from the brain of the hibernating ground squirrel on the EEG and behavior in rats. Neurosci. Behav. Physiol. 28, 158-166. doi:10.1007/BF02461962.
14. Inoue, M., Nakayamada, H., Tokuyama, S., and Ueda, H. (1997). Peripheral non-opioid analgesic effects of kyotorphin in mice. Neurosci. Lett. 236, 60-62. doi:10.1016/S0304-3940(97)00760-X.
15. Johnson, G., and Stoothoff, W. (2004). Tau phosphorylation in neuronal cell function and dysfunction. J. Cell. Sci. 117, 5721-5729. doi:10.1242/jcs.01558.
16. Knickman, J., and Snell, E. (2002). The 2030 problem: caring for aging baby boomers. Health Serv. Res. 37, 849-884. doi:10.1034/j.1600-0560.2002.56.x.
17. Kolaeva, S. G., Semenova, T. P., Santalova, I. M., Moshkov, D. A., Anoshkina, I. A., and Golozubova, V. (2000). Effects of L-thyrosyl-L-arginine (kyotorphin) on the behavior of rats and goldfish. Peptides 21, 1331-1336. doi:10.1016/S0196-9781(00)00275-8.
18. Kurz, A., Riemensschneider, M., Buck, K., Willoch, F., Bartenstein, P., Muller, U., et al. (1998). Tau protein in cerebro-spinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 12, 372-377. doi:10.1097/00002093-199812000-00020.
19. Li, Y., Saito, Y., Suzuki, M., Ueda, H., Endo, M., and Maruyama, K. (2006). Kyotorphin has a novel action on rat cardiac muscle. Biochem. Biophys. Res. Commun. 339, 805-809. doi:10.1016/j.bbrc.2005.11.081.
20. Nazarenko, I. V., Zvrushchenko, M., Volkov, A. V., Kamenskii, A. A., and Zaganshin, R. (1999). Functional-morphologic evaluation of the effect of the regulatory peptide kyotorphin on the status of the CNS in the post-resuscitation period. Patol. Fiziol. Eksp. Ter. 2, 31-33.
21. Nishimura, K., Kaya, K., Hazato, T., Ueda, H., Satoh, M., and Takagi, H. (1991). Kyotorphin like substance in human cerebrospinal fluid of patients with persistent pain. Masui 40, 1686-1690.
22. Rebollido-Fernandez, M. M., Castiñeiras, D. E., Bóveda, M. D., Couce, M. L., Cocho, J. A., and Fraga, J. M. (2012). Development of electrospray ionization tandem mass spectrometry methods for the study of a high number of urine markers of inborn errors of metabolism. Rapid Commun. Mass Spectrom. 26, 2131-2144. doi:10.1002/rcm.6325.
23. Ribeiro, M. M., Pinto, A., Pinto, M., Heras, M., Martins, I., Correia, A., et al. (2011a). Inhibition of nociceptive responses after systemic administration of amidated kyotorphin. Br. J. Pharmacol. 163, 964-973. doi:10.1111/j.1476-5381.2011.01290.x.
24. Ribeiro, M. M., Pinto, A. R., Domingues, M. M., Serrano, I., Heras, M., Bardaji, E. R., et al. (2011b). Chemical conjugation of the neuropeptide kyotorphin and ibuprofen enhances brain targeting and analgesia. Mol. Pharm. 8, 1929-1940. doi:10.1021/mp2003016.
25. Sabuncu, M. R., Desikan, R. S., Sepulcre, J., Yeo, B. T., Liu, H., Schmansky, N. J., et al. (2011). The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch. Neurol. 68, 1040-1048. doi:10.1001/archneurol.2011.167.
26. Santalova, I. M., Mavlyutov, T. A., and Moshkov, D. A. (2004). Morphofunctional changes in Mauthner neurons during exposure to the neuropeptide kyotorphin. Neurosci. Behav. Physiol. 34, 327-332. doi:10.1023/B:NEAB.0000018741.79726.70.
27. Seppälä, T. T., Nerg, O., Koivisto, A. M., Rummukainen, J., Puli, L., Zetterberg, H., et al. (2012). CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology 78, 1568-1575. doi:10.1212/WNL.0b013e3182563bd0.
28. Shandra, A. A. (1999). Role of neuropeptides in the mechanisms of chronic epileptization of the brain. Neurophysiology 31, 75-78. doi:10.1007/BF02515038.
29. Shiomi, H., Kuraishi, Y., Ueda, H., Harada, Y., Amano, H., and Takagi, H. (1981a). Mechanism of kyotorphin-induced release of Met-enkephalin from guinea pig striatum and spinal cord. Brain Res. 221, 161-169. doi:10.1016/0006-8993(81)91070-2.
30. Shiomi, H., Ueda, H., and Takagi, H. (1981b). Isolation and identification of an analgesic opioid dipeptide kyotorphin (Tyr-Arg) from bovine brain. Neuropharmacology 20, 633-638. doi:10.1016/0028-3908(81)90109-X.
31. Sulkava, R., Erkinjuntti, T., and Laatikainen, T. (1985). CSF beta-endorphin and beta-lipotropin in Alzheimer's disease and multi-infarct dementia. Neurology 35, 1057-1058. doi:10.1212/WNL.35.7.1057.
32. Takagi, H., Shiomi, H., Ueda, H., and Amano, H. (1979). Morphine-like analgesia by a new dipeptide, L-tyrosyl-L-arginine (kyotorphin) and its analogue. Eur. J. Pharmacol. 55, 109-111. doi:10.1016/0014-2999(79)90154-7.
33. Ueda, H., Shiomi, H., and Takagi, H. (1980). Regional distribution of a novel analgesic dipeptide kyotorphin (Tyr-Arg) in the rat brain and spinal cord. Brain Res. 198, 460-464. doi:10.1016/0006-8993(80)90761-1.
34. Ueda, H., Tatsumi, K., Shiomi, H., and Takagi, H. (1982). Analgesic dipeptide, kyotorphin (Tyr-Arg), is highly concentrated in the synaptosomal fraction of the rat brain. Brain Res. 231, 222-224. doi:10.1016/0006-8993(82)90023-3.